Analyze Diet

Topic:Western Equine Encephalitis

Western Equine Encephalitis (WEE) is a viral disease affecting horses, caused by the Western Equine Encephalitis virus, which is transmitted primarily through mosquito bites. The virus can lead to neurological symptoms in horses, such as fever, depression, ataxia, and encephalitis, which may progress to more severe neurological impairment or death. Diagnosis of WEE is typically based on clinical signs, serological testing, and virus isolation. Preventative measures include mosquito control and vaccination programs to reduce the risk of transmission. This page compiles peer-reviewed research studies and scholarly articles that explore the epidemiology, pathogenesis, clinical presentation, and management strategies for Western Equine Encephalitis in horses.
Eastern, Western, and Venezuelan Equine Encephalitis and West Nile Viruses: Clinical and Public Health Considerations.
The Veterinary clinics of North America. Equine practice    February 1, 2023   Volume 39, Issue 1 99-113 doi: 10.1016/j.cveq.2022.11.007
Luethy D.The continued recognition and emergence of alphavirus and flavivirus diseases is a growing veterinary and public health concern. As the global environment continues to change, mosquito-borne diseases will continue to evolve and expand. Continued development of readily available vaccines for the prevention of these diseases in humans and animals is essential to controlling epizootics of these diseases. Further research into effective antiviral treatments is also sorely needed. This article describes equine encephalitis viruses with a focus on clinical and public health considerations.
Advances in the Development of Small Molecule Antivirals against Equine Encephalitic Viruses.
Viruses    February 1, 2023   Volume 15, Issue 2 413 doi: 10.3390/v15020413
Ogorek TJ, Golden JE.Venezuelan, western, and eastern equine encephalitic alphaviruses (VEEV, WEEV, and EEEV, respectively) are arboviruses that are highly pathogenic to equines and cause significant harm to infected humans. Currently, human alphavirus infection and the resulting diseases caused by them are unmitigated due to the absence of approved vaccines or therapeutics for general use. These circumstances, combined with the unpredictability of outbreaks-as exemplified by a 2019 EEE surge in the United States that claimed 19 patient lives-emphasize the risks posed by these viruses, especially for aerosolized V...
Equids’ Core Vaccines Guidelines in North America: Considerations and Prospective.
Vaccines    March 4, 2022   Volume 10, Issue 3 doi: 10.3390/vaccines10030398
Desanti-Consoli H, Bouillon J, Chapuis RJJ.Vaccination against infectious diseases is a cornerstone of veterinary medicine in the prevention of disease transmission, illness severity, and often death in animals. In North American equine medicine, equine vaccines protecting against tetanus, rabies, Eastern and Western equine encephalomyelitis, and West Nile are core vaccines as these have been classified as having a heightened risk of mortality, infectiousness, and endemic status. Some guidelines differ from the label of vaccines, to improve the protection of patients or to decrease the unnecessary administration to reduce potential sid...
Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection.
Virology    September 28, 2021   Volume 565 13-21 doi: 10.1016/j.virol.2021.09.007
Calvert AE, Bennett SL, Hunt AR, Fong RH, Doranz BJ, Roehrig JT, Blair CD.Eastern equine encephalitis virus (EEEV), western equine encephalitis virus (WEEV) and Venezuelan equine encephalitis virus (VEEV) can cause fatal encephalitis in humans and equids. Some MAbs to the E1 glycoprotein are known to be cross-reactive, weakly neutralizing in vitro but can protect from disease in animal models. We investigated the mechanism of neutralization of VEEV infection by the broadly cross-reactive E1-specific MAb 1A4B-6. 1A4B-6 protected 3-week-old Swiss Webster mice prophylactically from lethal VEEV challenge. Likewise, 1A4B-6 inhibited virus growth in vitro at a pre-attachm...
Astrocyte inflammatory signaling mediates α-synuclein aggregation and dopaminergic neuronal loss following viral encephalitis.
Experimental neurology    August 26, 2021   Volume 346 113845 doi: 10.1016/j.expneurol.2021.113845
Bantle CM, Rocha SM, French CT, Phillips AT, Tran K, Olson KE, Bass TA, Aboellail T, Smeyne RJ, Tjalkens RB.Viral infection of the central nervous system (CNS) can cause lasting neurological decline in surviving patients and can present with symptoms resembling Parkinson's disease (PD). The mechanisms underlying postencephalitic parkinsonism remain unclear but are thought to involve increased innate inflammatory signaling in glial cells, resulting in persistent neuroinflammation. We therefore studied the role of glial cells in regulating neuropathology in postencephalitic parkinsonism by studying the involvement of astrocytes in loss of dopaminergic neurons and aggregation of α-synuclein protein fo...
Serological evidence of Eastern equine encephalitis circulation in equids in Pará state, Brazil.
Brazilian journal of veterinary medicine    March 31, 2021   Volume 43 e001720 doi: 10.29374/2527-2179.bjvm001720
Nunes JDSDSS, Casseb LMN, Guimarães RJPS, Reis WDM, de Barros BCV, Ferreira MS, Chiang JO, Pinheiro HHC, Vasconcelos PFDC, Cruz ACR.Serum samples from 89 equids were analyzed (75 horses, 9 donkeys, and 5 mules) from the municipality of Viseu, Pará state, Brazil. Samples were collected in November 2014 and August 2015. The antibody prevalence against the following alphaviruses was estimated: Eastern equine encephalitis virus, Western equine encephalitis virus, Mucambo virus, and Mayaro virus. Seroprevalence was determined by the hemagglutination inhibition (HI) technique. Sera that exhibited HI antibodies with heterotypic reactions for the analyzed viruses were subjected to the 90% plaque reduction neutralization test (PRN...
Continued Evidence of Decline in the Enzootic Activity of Western Equine Encephalitis Virus in Colorado.
Journal of medical entomology    December 12, 2018   Volume 56, Issue 2 584-588 doi: 10.1093/jme/tjy214
Robb LL, Hartman DA, Rice L, deMaria J, Bergren NA, Borland EM, Kading RC.Western equine encephalitis (WEE) was once prevalent and routinely isolated from mosquitoes in Colorado; however, isolations of Western equine encephalitis virus (WEEV) have not been reported from mosquito pools since the early 1990s. The objective of the present study was to test pools of Culex tarsalis (Coquillett) mosquitoes sampled from Weld County, CO, in 2016 for evidence of WEEV infection. Over 7,000 mosquitoes were tested, but none were positive for WEEV RNA. These data indicate that WEEV either was not circulating enzootically in Northern Colorado, was very rare, and would require muc...
Culex Tarsalis Mosquitoes as Vectors of Highlands J Virus.
Vector borne and zoonotic diseases (Larchmont, N.Y.)    June 1, 2016   Volume 16, Issue 8 558-565 doi: 10.1089/vbz.2015.1907
Borland EM, Ledermann JP, Powers AM.Highlands J virus (HJV) is an alphavirus closely related to western equine encephalitis virus (WEEV) and eastern equine encephalitis virus (EEEV). HJV is an avian pathogen with the potential for disruption of poultry operations, but is not known to cause human or equine disease. HJV has only been identified in the eastern United States and is thought to have a transmission cycle similar to that of EEEV involving Culiseta melanura mosquitoes and birds. However, HJV is more genetically similar to WEEV and it remains unclear if it may be transmitted by Culex species mosquitoes like WEEV. Seven st...
The ubiquitin proteasome system plays a role in venezuelan equine encephalitis virus infection.
PloS one    April 30, 2015   Volume 10, Issue 4 e0124792 doi: 10.1371/journal.pone.0124792
Amaya M, Keck F, Lindquist M, Voss K, Scavone L, Kehn-Hall K, Roberts B, Bailey C, Schmaljohn C, Narayanan A.Many viruses have been implicated in utilizing or modulating the Ubiquitin Proteasome System (UPS) to enhance viral multiplication and/or to sustain a persistent infection. The mosquito-borne Venezuelan equine encephalitis virus (VEEV) belongs to the Togaviridae family and is an important biodefense pathogen and select agent. There are currently no approved vaccines or therapies for VEEV infections; therefore, it is imperative to identify novel targets for therapeutic development. We hypothesized that a functional UPS is required for efficient VEEV multiplication. We have shown that at non-tox...
Characterisation of immune responses in healthy foals when a multivalent vaccine protocol was initiated at age 90 or 180 days.
Equine veterinary journal    December 30, 2014   Volume 47, Issue 6 667-674 doi: 10.1111/evj.12350
Davis EG, Bello NM, Bryan AJ, Hankins K, Wilkerson M.Protection from infectious disease requires antigen-specific immunity. In foals, most vaccine protocols are delayed until 6 months to avoid maternal antibody interference. Susceptibility to disease may exist prior to administration of vaccination at age 4-6 months. Objective: The aim of this investigation was to characterise immune activation among healthy foals in response to a multivalent vaccine protocol and compare immune responses when foals were vaccinated at age either 90 or 180 days. Methods: Randomised block design. Methods: Twelve healthy foals with colostral transfer were blocked fo...
Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.
Journal of virology    August 13, 2014   Volume 88, Issue 20 12077-12086 doi: 10.1128/JVI.01406-14
Reed DS, Glass PJ, Bakken RR, Barth JF, Lind CM, da Silva L, Hart MK, Rayner J, Alterson K, Custer M, Dudek J, Owens G, Kamrud KI, Parker MD, Smith J.Alphavirus replicons were evaluated as potential vaccine candidates for Venezuelan equine encephalitis virus (VEEV), western equine encephalitis virus (WEEV), or eastern equine encephalitis virus (EEEV) when given individually or in combination (V/W/E) to mice or cynomolgus macaques. Individual replicon vaccines or the combination V/W/E replicon vaccine elicited strong neutralizing antibodies in mice to their respective alphavirus. Protection from either subcutaneous or aerosol challenge with VEEV, WEEV, or EEEV was demonstrated out to 12 months after vaccination in mice. Individual replicon v...
Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivo.
Journal of virology    July 16, 2014   Volume 88, Issue 19 11199-11214 doi: 10.1128/JVI.01671-14
Delekta PC, Dobry CJ, Sindac JA, Barraza SJ, Blakely PK, Xiang J, Kirchhoff PD, Keep RF, Irani DN, Larsen SD, Miller DJ.Neurotropic alphaviruses, including western, eastern, and Venezuelan equine encephalitis viruses, cause serious and potentially fatal central nervous system infections in humans for which no currently approved therapies exist. We previously identified a series of thieno[3,2-b]pyrrole derivatives as novel inhibitors of neurotropic alphavirus replication, using a cell-based phenotypic assay (W. Peng et al., J. Infect. Dis. 199:950-957, 2009, doi:http://dx.doi.org/10.1086/597275), and subsequently developed second- and third-generation indole-2-carboxamide derivatives with improved potency, solub...
Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2.
PLoS pathogens    June 26, 2014   Volume 10, Issue 6 e1004213 doi: 10.1371/journal.ppat.1004213
Chung DH, Jonsson CB, Tower NA, Chu YK, Sahin E, Golden JE, Noah JW, Schroeder CE, Sotsky JB, Sosa MI, Cramer DE, McKellip SN, Rasmussen L, White EL....Alphaviruses present serious health threats as emerging and re-emerging viruses. Venezuelan equine encephalitis virus (VEEV), a New World alphavirus, can cause encephalitis in humans and horses, but there are no therapeutics for treatment. To date, compounds reported as anti-VEEV or anti-alphavirus inhibitors have shown moderate activity. To discover new classes of anti-VEEV inhibitors with novel viral targets, we used a high-throughput screen based on the measurement of cell protection from live VEEV TC-83-induced cytopathic effect to screen a 340,000 compound library. Of those, we identified...
Identification of hotspots in the European union for the introduction of four zoonotic arboviroses by live animal trade.
PloS one    July 23, 2013   Volume 8, Issue 7 e70000 doi: 10.1371/journal.pone.0070000
Durand B, Lecollinet S, Beck C, Martínez-López B, Balenghien T, Chevalier V.Live animal trade is considered a major mode of introduction of viruses from enzootic foci into disease-free areas. Due to societal and behavioural changes, some wild animal species may nowadays be considered as pet species. The species diversity of animals involved in international trade is thus increasing. This could benefit pathogens that have a broad host range such as arboviruses. The objective of this study was to analyze the risk posed by live animal imports for the introduction, in the European Union (EU), of four arboviruses that affect human and horses: Eastern and Western equine enc...
Molecular determinants of mouse neurovirulence and mosquito infection for Western equine encephalitis virus.
PloS one    March 27, 2013   Volume 8, Issue 3 e60427 doi: 10.1371/journal.pone.0060427
Mossel EC, Ledermann JP, Phillips AT, Borland EM, Powers AM, Olson KE.Western equine encephalitis virus (WEEV) is a naturally occurring recombinant virus derived from ancestral Sindbis and Eastern equine encephalitis viruses. We previously showed that infection by WEEV isolates McMillan (McM) and IMP-181 (IMP) results in high (∼90-100%) and low (0%) mortality, respectively, in outbred CD-1 mice when virus is delivered by either subcutaneous or aerosol routes. However, relatively little is known about specific virulence determinants of WEEV. We previously observed that IMP infected Culex tarsalis mosquitoes at a high rate (app. 80%) following ingestion of an in...
Serological evidence of flaviviruses and alphaviruses in livestock and wildlife in Trinidad.
Vector borne and zoonotic diseases (Larchmont, N.Y.)    September 18, 2012   Volume 12, Issue 11 969-978 doi: 10.1089/vbz.2012.0959
Thompson NN, Auguste AJ, Coombs D, Blitvich BJ, Carrington CV, da Rosa AP, Wang E, Chadee DD, Drebot MA, Tesh RB, Weaver SC, Adesiyun AA.Seroprevalence rates of selected arboviruses in animal populations in Trinidad were determined using serum samples collected between 2006 and 2009 from horses (n=506), cattle (n=163), sheep (n=198), goats (n=82), pigs (n=184), birds (n=140), rodents (n=116), and other vertebrates (n=23). The sera were screened for antibodies to West Nile virus (WNV), St. Louis encephalitis virus (SLEV), Ilheus virus (ILHV), Bussuquara virus (BSQV), Venezuelan equine encephalitis virus (VEEV), eastern equine encephalitis virus (EEEV), and western equine encephalitis virus (WEEV), using hemagglutination inhibiti...
Factors affecting recombinant Western equine encephalitis virus glycoprotein production in the baculovirus system.
Protein expression and purification    August 16, 2011   Volume 80, Issue 2 274-282 doi: 10.1016/j.pep.2011.08.002
Toth AM, Geisler C, Aumiller JJ, Jarvis DL.In an effort to produce processed, soluble Western equine encephalitis virus (WEEV) glycoproteins for subunit therapeutic vaccine studies, we isolated twelve recombinant baculoviruses designed to express four different WEEV glycoprotein constructs under the transcriptional control of three temporally distinct baculovirus promoters. The WEEV glycoprotein constructs encoded full-length E1, the E1 ectodomain, an E26KE1 polyprotein precursor, and an artificial, secretable E2E1 chimera. The three different promoters induced gene expression during the immediate early (ie1), late (p6.9), and very lat...
Fatal human case of Western equine encephalitis, Uruguay.
Emerging infectious diseases    May 3, 2011   Volume 17, Issue 5 952-954 doi: 10.3201/eid1705.101068
Delfraro A, Burgueño A, Morel N, González G, García A, Morelli J, Pérez W, Chiparelli H, Arbiza J.No abstract available
Envelope protein E1 as vaccine target for western equine encephalitis virus.
Vaccine    December 3, 2010   Volume 29, Issue 4 813-820 doi: 10.1016/j.vaccine.2010.11.009
Swayze RD, Bhogal HS, Barabé ND, McLaws LJ, Wu JQ.Western equine encephalitis virus (WEEV) is a mosquito-borne RNA virus which causes lethal infection in humans and equines. There are no commercial vaccines or anti-WEEV drugs available for humans. We used replication-defective, human adenovirus serotype-5 (HAd5) as a delivery vector for developing WEEV vaccine. Our previous study found delivery of both E1 and E2 envelope proteins of WEEV by HAd5 vector offers complete protection against lethal challenge of WEEV. In this paper, we constructed a HAd5-vectored E1 vaccine, Ad5-E1. Mice given single-dose vaccination of Ad5-E1 were completely prote...
REVIEW PAPER: pathology of animal models of alphavirus encephalitis.
Veterinary pathology    June 15, 2010   Volume 47, Issue 5 790-805 doi: 10.1177/0300985810372508
Steele KE, Twenhafel NA.The encephalitides caused by Venezuelan (VEEV), eastern (EEEV), and western (WEEV) equine encephalitis viruses are important natural diseases of horses and humans and potential agents of biowarfare or bioterrorism. No licensed vaccines or specific therapies exist to prevent or treat human infections with VEEV, EEEV, or WEEV. Well-characterized animal models are needed to support the development of such medical countermeasures under the United States Food and Drug Administration's "Animal Rule." This review focuses on the pathological features and pathogenetic mechanisms of these alphaviral enc...
Alphavirus antiviral drug development: scientific gap analysis and prospective research areas.
Biosecurity and bioterrorism : biodefense strategy, practice, and science    December 24, 2009   Volume 7, Issue 4 413-427 doi: 10.1089/bsp.2009.0032
Reichert E, Clase A, Bacetty A, Larsen J.The New World alphaviruses Venezuelan equine encephalitis virus (VEEV), eastern equine encephalitis virus (EEEV), and western equine encephalitis virus (WEEV) pose a significant threat to human health as the etiological agents of serious viral encephalitis through natural infection as well as through their potential use as a biological weapon. At present, there is no FDA-approved medical treatment for infection with these viruses. The Defense Threat Reduction Agency, Joint Science and Technology Office for Chemical and Biological Defense (DTRA/JSTO), is currently funding research aimed at deve...
Identification of Western equine encephalitis virus structural proteins that confer protection after DNA vaccination.
Clinical and vaccine immunology : CVI    November 18, 2009   Volume 17, Issue 1 176-179 doi: 10.1128/CVI.00377-09
Gauci PJ, Wu JQ, Rayner GA, Barabé ND, Nagata LP, Proll DF.DNA vaccines encoding different portions of the structural proteins of western equine encephalitis virus were tested for the efficacy of their protection in a 100% lethal mouse model of the virus. The 6K-E1 structural protein encoded by the DNA vaccine conferred complete protection against challenge with the homologous strain and limited protection against challenge with a heterologous strain.
Western Equine Encephalitis submergence: lack of evidence for a decline in virus virulence.
Virology    September 17, 2008   Volume 380, Issue 2 170-172 doi: 10.1016/j.virol.2008.08.012
Forrester NL, Kenney JL, Deardorff E, Wang E, Weaver SC.The incidence of Western Equine Encephalitis (WEE) in humans and equids peaked during the mid-20th century and has declined to fewer than 1-2 human cases annually during the past 20 years. Using the mouse model, changes in WEE virus (WEEV) virulence were investigated as a potential explanation for the decline in the number of cases. Evaluation of 10 WEEV strains representing a variety of isolation locations, hosts, and all decades from the 1940's to the 1990's yielded no evidence of a decline in virulence. These results suggest that ecological factors affecting human and equine exposure should...
Limited interdecadal variation in mosquito (Diptera: Culicidae) and avian host competence for Western equine encephalomyelitis virus (Togaviridae: Alphavirus).
The American journal of tropical medicine and hygiene    April 4, 2008   Volume 78, Issue 4 681-686 
Reisen WK, Fang Y, Brault AC.Historically, western equine encephalomyelitis virus (WEEV) caused large equine and human epidemics in the Americas from Canada into Argentina. Despite recent enhanced surveillance for West Nile virus, there have been few reports of equine or human cases and little documented enzootic activity of WEEV. During the past three years, WEEV has been active again in California, but without human or equine cases. In the current study, we compared host and vector competence of representative WEEV isolates made during each decade over the past 60 years using white-crowned sparrows, house sparrows, and ...
Cloning, expression and purification of envelope proteins E1 and E2 of western equine encephalitis virus and potential use of them as antigens in immunoassays.
Veterinary microbiology    December 3, 2007   Volume 128, Issue 3-4 374-379 doi: 10.1016/j.vetmic.2007.10.022
Hu WG, Chau D, Wong C, Masri SA, Fulton RE, Nagata LP.The genes encoding envelope proteins E1 and E2 of western equine encephalitis virus (WEEV) were respectively cloned into a prokaryotic T7 RNA polymerase-regulated expression vector. The recombinant C-terminal 6xHis-tagged WEEV E1 and E2 were expressed in bacteria as inclusion bodies that were subsequently solubilized with 8M urea, purified by immobilized metal ion affinity chromatography and finally refolded using an arginine system. The purified 6xHis-tagged proteins showed 50kDa bands as revealed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis, consistent with the expected size...
Efficacy of DNA vaccination against western equine encephalitis virus infection.
Vaccine    March 10, 2005   Volume 23, Issue 17-18 2280-2283 doi: 10.1016/j.vaccine.2005.01.032
Nagata LP, Hu WG, Masri SA, Rayner GA, Schmaltz FL, Das D, Wu J, Long MC, Chan C, Proll D, Jager S, Jebailey L, Suresh MR, Wong JP.The efficacy of a DNA vaccine against western equine encephalitis (WEE) infection in mice was evaluated. The 26S structural region was expressed, in vitro from an internal T7 promoter using a rabbit reticulysate transcription/translation system; and from a CMV promoter after transfection into Vero cell monolayers. The proteins synthesized were reactive with anti-WEE virus (WEEV) antibodies, both in western blot analysis and histochemical staining, respectively. When the DNA vaccine plasmid, pVHX-6, was administered intraepidermally to mice, followed by challenge in a lethal mouse model, the le...
California state Mosquito-Borne Virus Surveillance and Response Plan: a retrospective evaluation using conditional simulations.
The American journal of tropical medicine and hygiene    June 19, 2003   Volume 68, Issue 5 508-518 doi: 10.4269/ajtmh.2003.68.508
Barker CM, Reisen WK, Kramer VL.The California Mosquito-Borne Virus Surveillance and Response Plan recently was developed to provide a semi-quantitative means for assessing risk for western equine encephalomyelitis (WEE) or St. Louis encephalitis (SLE) viruses and to provide intervention guidelines for mosquito control and public health agencies during periods of heightened risk for human infection. West Nile virus recently has arrived in California, and the response plan also will provide a baseline for assessing the risk for human and equine infection with this virus. In the response plan, overall risk is calculated by ave...
Serologic survey of domestic animals for zoonotic arbovirus infections in the Lacandón Forest region of Chiapas, Mexico.
Vector borne and zoonotic diseases (Larchmont, N.Y.)    June 14, 2003   Volume 3, Issue 1 3-9 doi: 10.1089/153036603765627406
Ulloa A, Langevin SA, Mendez-Sanchez JD, Arredondo-Jimenez JI, Raetz JL, Powers AM, Villarreal-Treviño C, Gubler DJ, Komar N.A serologic survey in domestic animals (birds and mammals) was conducted in four communities located in the Lacandón Forest region of northeastern Chiapas, Mexico, during June 29 to July 1, 2001, with the objective to identify zoonotic arboviruses circulating in this area. We collected 202 serum samples from healthy domestic chickens, geese, ducks, turkeys, horses and cattle. The samples were tested by plaque-reduction neutralization test for antibodies to selected mosquito-borne flaviviruses (family Flaviviridae), including St. Louis encephalitis (SLE), Rocio (ROC), Ilheus (ILH), Bussuquara ...
Initiating arbovirus surveillance in Arkansas, 2001.
Journal of medical entomology    April 16, 2003   Volume 40, Issue 2 223-229 doi: 10.1603/0022-2585-40.2.223
Kent RJ, Lacer LD, Meisch MV.Migratory birds could introduce West Nile (WN) virus to Arkansas. The purpose of this study was to establish a cooperative arbovirus surveillance program to monitor mosquitoes and birds in Arkansas for arboviruses. Our objectives were to: 1) perform routine, multicounty collections of mosquitoes and test them for eastern equine encephalitis, St. Louis encephalitis, and WN viruses; and 2) conduct passive surveillance by testing dead wild birds for WN virus. Arbovirus surveillance was organized by the Arkansas Department of Health, University of Arkansas, and Vector Disease Control Incorporated....
Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates.
The American journal of tropical medicine and hygiene    March 19, 2003   Volume 68, Issue 2 218-221 
Turell MJ, O'Guinn ML, Parker MD.Specific mutations associated with attenuation of Venezuelan equine encephalitis (VEE) virus in rodent models were identified during efforts to develop an improved VEE vaccine. Analogous mutations were produced in full-length cDNA clones of the Cba 87 strain of western equine encephalitis (WEE) virus by site-directed mutagenesis in an attempt to develop an improved WEE vaccine. Isogenic viral strains with these mutations were recovered after transfection of baby hamster kidney cells with infectious RNA. We evaluated two of these strains (WE2102 and WE2130) for their ability to replicate in and...
1 2 3 5